| | | Another week of sad trombones, though once again the biotech indices were less bad (off -1.1% or -1.6%) than the NASDAQ composite (down -4.2%).
In the list of “winner” stocks for last week, there are no big standouts. Indeed the top stock is the Candian firm BTI.V, up 26% for the week to a weekly “close” at 19 cents (Canadian). But this result is pretty tenuous in that the stock is extremely thinly traded, with only four (!) trades during the week, the last being 300 shares late Thursday for 19 cents, with a fairly large spread (the “bid” value was 15.5 cents and the “Ask” was 19 cents) (The Toronto exchange was closed Friday). The previous sale was 10,500 shares at the market open Wednesday for 15.5 cents, the same price given for the weekly open, and only a 3% improvement on last weeks close.
Then there is the second place finisher, AYLA, whose +18.7% gain built on the previous week’s +26.7%. But, both week’s action was restricted to trades on Friday, with no apparent news either week to justify the change, On the losing side, CABA crashed on Monday (off f-47% for the week), almost certainly based on disappoint with an update on a drug trial presented at the EADV Congress that day. The second worst loser, TOMDF, -33%, more than erased it’s previous week's second place gain of +35%.
As previously mentioned, ATHX had a 25 to 1 reverse split, reflecting a poor performance.
In contrast to other recent weeks, the contest portfolios generally were bigger losers than the bio-tech indices, dropping -2.2% in the median for the week. As a result now all of the portfolios have slipped into the red, YTD, and only six of the portfolios managed a net positive for the week, though the top five of the list are members of the the top ten YTD list, which might say something. They obviously tended to improve their position in the list, which mixed up the order of the 3rd to 10th place YTD portfolios. Bulbaman took his 3rd place finish in the week’s performance to return to the top ten YTD list after only a single week’s absence.
|
Report Time Ranges
|
|
|
From
|
To
|
Recent
|
8/26/22
|
9/2/22
|
YTD
|
12/31/21
|
Index Performance
|
|
Symbol
|
Recent
|
YTD
|
|
^IXIC
|
-4.21%
|
-25.66%
|
^NBI
|
-1.14%
|
-18.13%
|
^SPSIBI
|
-1.57%
|
-25.21%
|
Share Performance
|
Recent
|
YTD
|
Top 5
|
Bottom 5
|
Top 5
|
Bottom 5
|
BTI.V
|
26.667%
|
CABA
|
-47.374%
|
OPTN
|
122.84%
|
GNCA
|
-99.13%
|
AYLA
|
18.675%
|
TOMDF
|
-32.840%
|
CBIO
|
113.35%
|
VLON
|
-93.48%
|
OMER
|
18.063%
|
ATHX
|
-22.154%
|
ALDX
|
73.50%
|
PTE
|
-93.12%
|
FULC
|
12.917%
|
RNLX
|
-22.134%
|
FENC
|
67.95%
|
PLXP
|
-90.51%
|
APLS
|
12.287%
|
LQDA
|
-21.971%
|
ESPR
|
57.20%
|
PRQR
|
-90.39%
|
|
Top 10 Portfolio YTD
|
YTD(Portfolio - SPSIBI)
|
Rec
|
Rec(Port. - SPSIBI)
|
DIEGOSAN
|
-0.85%
|
24.37%
|
-1.470%
|
0.096%
|
BRENDAN_49
|
-10.80%
|
14.41%
|
-2.298%
|
-0.732%
|
DEW DILIGENCE
|
-11.07%
|
14.15%
|
2.715%
|
4.281%
|
TECHNETIUM
|
-15.98%
|
9.24%
|
2.223%
|
3.789%
|
GENEGURU
|
-19.13%
|
6.08%
|
-7.098%
|
-5.532%
|
BIOSCIENTISTSA
|
-20.00%
|
5.21%
|
1.327%
|
2.893%
|
KMASTRA
|
-20.01%
|
5.21%
|
-0.705%
|
0.861%
|
JACK HARTMANN
|
-23.97%
|
1.25%
|
1.642%
|
3.208%
|
BULBAMAN
|
-24.19%
|
1.02%
|
1.822%
|
3.388%
|
A.J. MULLEN
|
-25.32%
|
-0.10%
|
-1.980%
|
-0.414%
|
Average and Median Portfolio Performance
|
|
Avg Recent
|
Avg YTD
|
Median Recent
|
Median YTD
|
|
-$1,507
|
-33.34%
|
ETHAN H
|
-$1,543
|
MOPGCW
|
-36.10%
|
-2.40%
|
ETHAN H
|
-2.182%
|
|
|
